News|Articles|August 5, 2014
BioSpectra Opens Contract Manufacturing Facility
Author(s)Pharmaceutical Technology Editors
BioSpectra's Pennsylvania facility will manufacture biological buffers, pharmaceutical excipients, and laboratory reagents.
Advertisement
BioSpectra opened an FDA-registered facility in Bangor, Pennsylvania, US for contract-manufactured products for pharmaceutical, biopharmaceutical, and drug manufacturing markets.
BioSpectra provides custom cGMP purifications, acidifications, acid/base reactions, custom formulations, and particle manipulation backed by fully-documented regulatory support using ICHQ7 manufacturing systems. The company produces biological buffers, pharmaceutical excipients, and laboratory reagents.
Source:
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Technology Transfer: Success Drivers and Obstacles Explained
2
European Regulators Prepare the Pharma Industry for Future Changes as Legislation is Formalized
3
Assessment of Silicone Oil Cleaning on Indirect Surfaces in Aseptic Manufacturing
4
Why Oral Solid Dosage Validation Is a Business Continuity Function, Not Just a Compliance Requirement
5